OECD Report On Health Care Spending

24 October 1994

Most of the other 23 nations in a new study from the Organization for Economic Cooperation and Development spend less than half as much per person as the USA on health care. the USA spent $3,094 per person in 1992, or 13.6% of its Gross Domestic Product, said the study, published in health Affairs, and the spending gap with other major countries is widening.

The USA had the fifth highest infant mortality rate (after Turkey, Portugal, Luxembourg and Greece) and the highest percentage of babies with low birth weight.

The report found per capita health spending is climbing higher than consumer prices. Since 1980, health care spending has grown 4.6% a year more than prices in the USA, 2.8% more in Canada, 3.4% in France, 2.5% in Germany, 3.5% in Japan and 3.3% in the UK. Canada spent 10.3% of its GDP, or $1,949 per resident on health in 1992, while Finland spent 9.4% or $1,363, France 9.4% or $1,745, Switzerland 9.3% or $2,068, germany 8.7% or $1,775, Italy 8.5% or $1,497, the UK 7.1% or $1,151, Japan 6.9% or $1,376, and Turkey 4.1% or $156.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight